UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial

The lancet. Diabetes & endocrinology, 2017-05, Vol.5 (5), p.341-354

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of COVID-19 Lockdown on Anthropometric Variables, Blood Pressure, and Glucose and Lipid Profile in Healthy Adults: A before and after Pandemic Lockdown Longitudinal Study

Nutrients, 2022-03, Vol.14 (6), p.1237

2022

Link zum Volltext

Verfügbarkeit prüfen

Phytate Intake, Health and Disease: "Let Thy Food Be Thy Medicine and Medicine Be Thy Food"

Antioxidants, 2023-01, Vol.12 (1), p.146

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of COVID-19 Lockdown on Non-Alcoholic Fatty Liver Disease and Insulin Resistance in Adults: A before and after Pandemic Lockdown Longitudinal Study

Nutrients, 2022-07, Vol.14 (14), p.2795

2022

Link zum Volltext

Verfügbarkeit prüfen

Circulating Neurofilament Light Chain Levels Increase with Age and Are Associated with Worse Physical Function and Body Composition in Men but Not in Women

International journal of molecular sciences, 2023-08, Vol.24 (16), p.12751

2023

Link zum Volltext

Verfügbarkeit prüfen

Organoids: An Emerging Tool to Study Aging Signature across Human Tissues. Modeling Aging with Patient-Derived Organoids

International journal of molecular sciences, 2021-09, Vol.22 (19), p.10547

2021

Link zum Volltext

Verfügbarkeit prüfen

Daily phytate intake increases adiponectin levels among patients with diabetes type 2: a randomized crossover trial

Nutrition & diabetes, 2023-02, Vol.13 (1), p.2-2, Article 2

2023

Link zum Volltext

Verfügbarkeit prüfen

GDF15 and ACE2 stratify COVID-19 patients according to severity while ACE2 mutations increase infection susceptibility

Frontiers in cellular and infection microbiology, 2022-07, Vol.12, p.942951-942951

2022

Link zum Volltext

Verfügbarkeit prüfen

Role of Advanced Glycation End Products on Aortic Calcification in Patients with Type 2 Diabetes Mellitus

Journal of clinical medicine, 2020-06, Vol.9 (6), p.1751

2020

Link zum Volltext

Verfügbarkeit prüfen

Age-standardized incidence, mortality rate, and trend changes of thyroid cancer in the Balearic Islands during the 2000-2020 period: a population-based study

European thyroid journal, 2023-06, Vol.12 (3), p.1-9

2023

Link zum Volltext

Verfügbarkeit prüfen

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

The New England journal of medicine, 2016-07, Vol.375 (4), p.311-322

2016

Link zum Volltext

Verfügbarkeit prüfen

Liraglutide and Renal Outcomes in Type 2 Diabetes

The New England journal of medicine, 2017-08, Vol.377 (9), p.839-848

2017

Link zum Volltext

Verfügbarkeit prüfen

Phytate Decreases Formation of Advanced Glycation End-Products in Patients with Type II Diabetes: Randomized Crossover Trial

Scientific reports, 2018-06, Vol.8 (1), p.9619-13, Article 9619

2018

Link zum Volltext

Verfügbarkeit prüfen

Diabetes mellitus and cardiovascular clinical characteristics of Spanish women with stable ischaemic heart disease: Data from the SIRENA study

Diabetes research and clinical practice, 2017-01, Vol.123, p.82-86

2017

Link zum Volltext

Verfügbarkeit prüfen

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

The Lancet (British edition), 2019-07, Vol.394 (10193), p.121-130

2019

Link zum Volltext

Verfügbarkeit prüfen

Diabetes mellitus and cardiovascular clinical characteristics of Spanish women with stable ischemic heart disease: data from the SIRENA study

Diabetes research and clinical practice, 2016

2016

Link zum Volltext

Verfügbarkeit prüfen

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

The Lancet (British edition), 2019-07, Vol.394 (10193), p.131-138

2019

Link zum Volltext

Verfügbarkeit prüfen

LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial

Journal of hypertension, 2016-06, Vol.34 (6), p.1140-1150

2016

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular Risk Profile in Mediterranean Patients Submitted to Bariatric Surgery and Intensive Lifestyle Intervention: Impact of Both Interventions After 1 Year of Follow-Up

Obesity surgery, 2015-01, Vol.25 (1), p.97-108

2015

Link zum Volltext

Verfügbarkeit prüfen

14 - Semaglutide Reduces Body Weight Across Baseline BMI Subgroups Across SUSTAIN 1–5

Canadian journal of diabetes, 2017-10, Vol.41 (5), p.S6-S6

2017

Link zum Volltext

Verfügbarkeit prüfen

Semaglutide Reduces Body Weight Across Baseline BMI Subgroups Across SUSTAIN 1–5

Canadian journal of diabetes, 2017-10, Vol.41 (5), p.S6

2017

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive management of risk factors in peripheral vascular disease. Expert consensus

Revista clínica espanõla (English edition), 2022-02, Vol.222 (2), p.82-90

2022

Link zum Volltext

Verfügbarkeit prüfen

New Insights on Obstructive Sleep Apnea Syndrome and Related Comorbidities in Morbidly Obese Patients Submitted to Bariatric Surgery

Obesity surgery, 2014-11, Vol.24 (11), p.1995-1998

2014

Link zum Volltext

Verfügbarkeit prüfen

15 - Efficacy and Safety of Once-Weekly Semaglutide vs. Sitagliptin as Add-on to Metformin and/or Thiazolidinediones after 56 Weeks in Subjects with Type 2 Diabetes (SUSTAIN 2)

Canadian journal of diabetes, 2016-10, Vol.40 (5), p.S6-S6

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Once-Weekly Semaglutide vs. Sitagliptin as Add-on to Metformin and/or Thiazolidinediones after 56 Weeks in Subjects with Type 2 Diabetes (SUSTAIN 2)

Canadian journal of diabetes, 2016-10, Vol.40 (5), p.S6-S6

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(44)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(27)
Humans
(23)
Diabetes
(14)
Female
(14)
Male
(13)
Middle Aged
(13)
Risk Factors
(13)
Aged
(11)
Endocrinology & Metabolism
(10)
Blood Pressure
(8)
Diabetes Mellitus
(8)
Diabetes Mellitus, Type 2 - Drug Therapy
(8)
Cardiovascular Disease
(7)
Cardiovascular Diseases
(6)
Diabetes Mellitus, Type 2 - Complications
(6)
General & Internal Medicine
(6)
Glucagon
(6)
Hypoglycemic Agents - Therapeutic Use
(6)
Medicin Och Hälsovetenskap
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial

Impact of COVID-19 Lockdown on Anthropometric Variables, Blood Pressure, and Glucose and Lipid Profile in Healthy Adults: A before and after Pandemic Lockdown Longitudinal Study

Phytate Intake, Health and Disease: "Let Thy Food Be Thy Medicine and Medicine Be Thy Food"

Impact of COVID-19 Lockdown on Non-Alcoholic Fatty Liver Disease and Insulin Resistance in Adults: A before and after Pandemic Lockdown Longitudinal Study

Circulating Neurofilament Light Chain Levels Increase with Age and Are Associated with Worse Physical Function and Body Composition in Men but Not in Women

Organoids: An Emerging Tool to Study Aging Signature across Human Tissues. Modeling Aging with Patient-Derived Organoids

Daily phytate intake increases adiponectin levels among patients with diabetes type 2: a randomized crossover trial

GDF15 and ACE2 stratify COVID-19 patients according to severity while ACE2 mutations increase infection susceptibility

Role of Advanced Glycation End Products on Aortic Calcification in Patients with Type 2 Diabetes Mellitus

Age-standardized incidence, mortality rate, and trend changes of thyroid cancer in the Balearic Islands during the 2000-2020 period: a population-based study

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

Liraglutide and Renal Outcomes in Type 2 Diabetes

Phytate Decreases Formation of Advanced Glycation End-Products in Patients with Type II Diabetes: Randomized Crossover Trial

Diabetes mellitus and cardiovascular clinical characteristics of Spanish women with stable ischaemic heart disease: Data from the SIRENA study

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Diabetes mellitus and cardiovascular clinical characteristics of Spanish women with stable ischemic heart disease: data from the SIRENA study

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial

Cardiovascular Risk Profile in Mediterranean Patients Submitted to Bariatric Surgery and Intensive Lifestyle Intervention: Impact of Both Interventions After 1 Year of Follow-Up

14 - Semaglutide Reduces Body Weight Across Baseline BMI Subgroups Across SUSTAIN 1–5

Semaglutide Reduces Body Weight Across Baseline BMI Subgroups Across SUSTAIN 1–5

Comprehensive management of risk factors in peripheral vascular disease. Expert consensus

New Insights on Obstructive Sleep Apnea Syndrome and Related Comorbidities in Morbidly Obese Patients Submitted to Bariatric Surgery

15 - Efficacy and Safety of Once-Weekly Semaglutide vs. Sitagliptin as Add-on to Metformin and/or Thiazolidinediones after 56 Weeks in Subjects with Type 2 Diabetes (SUSTAIN 2)

Efficacy and Safety of Once-Weekly Semaglutide vs. Sitagliptin as Add-on to Metformin and/or Thiazolidinediones after 56 Weeks in Subjects with Type 2 Diabetes (SUSTAIN 2)

Suchergebnisse filtern